Found: 7
Select item for more details and to access through your institution.
CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 7, p. 3003, doi. 10.1172/JCI73048
- By:
- Publication type:
- Article
Paediatric Burkitt lymphoma patient‐derived xenografts capture disease characteristics over time and are a model for therapy.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 2, p. 354, doi. 10.1111/bjh.17043
- By:
- Publication type:
- Article
The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-13315-x
- By:
- Publication type:
- Article
The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-13315-x
- By:
- Publication type:
- Article
Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-47771-x
- By:
- Publication type:
- Article
One-step immortalization of primary human airway epithelial cells capable of oncogenic transformation.
- Published in:
- Cell & Bioscience, 2016, v. 6, p. 1, doi. 10.1186/s13578-016-0122-6
- By:
- Publication type:
- Article
Biomarker Testing Journey Among Patients with Advanced Solid Tumors and Treatment Patterns by Homologous Recombination Repair Status: A Clinico-Genomic Database Study.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 2, p. 759, doi. 10.1007/s12325-023-02734-4
- By:
- Publication type:
- Article